[Updated 2018 ASCO/CAP recommendations on the definition of human epidermal growth factor receptor type 2 (HER2) in breast cancer].

Autor:	Zavalishina LE; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia., Andreeva YY; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia., Olyushina EM; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia., Moskvina LV; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia., Frank GA; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Arkhiv patologii [Arkh Patol] 2019; Vol. 81 (6), pp. 82-85.
DOI:	10.17116/patol20198106182
Abstrakt:	A summary of the updated recommendations of the 2018 American Society of Clinical Oncology (ASCO) / College of American Pathologists (CAP), devoted to testing type 2 human epidermal growth factor receptor (HER2) in breast cancer.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu